Advance in the pathogenesis and treatment of acute promyelocytic leukemia / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 636-638, 2009.
Artículo
en Chino
| WPRIM
| ID: wpr-460133
ABSTRACT
Pathogenesis of acute promyelocytic leukemia is one of the best understood disease among human hematological malignancies. Becasue of retinoic acid (RA) and arsenic trioxide which directly target the oncogenic promyelocytic leukemia-retinoic receptor A (PML-RARα) fusion protein, this disease became the first model for oncogene-targeted therapies.And other new therapy methods also gain great concern. The complexity of recent views of acute promyelocytic leukemia pathogenesis, as well as latest progress in clinical treatment were summarized and discussed in this review.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio de etiología
Idioma:
Chino
Revista:
Journal of Leukemia & Lymphoma
Año:
2009
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS